Predictors and management of right heart failure after left ventricular assist device implantation

Nadia Fida, Matthias Loebe, Jerry D. Estep, Ashrith Guha

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Newer generation continuous-flow left ventricular assist devices (LVADs) have overall improved outcomes with lower incidences of right ventricular failure (RVF) than their pulsatile predecessors, yet RVF still occurs in 9% to 40% of LVAD recipients. Post-implant, RVF is associated with poor outcomes, end-organ dysfunction, high mortality, and reduced survival to transplant. Therefore, preoperative risk stratification, appropriate patient selection, and optimal timing of implant are of paramount importance. In this article, we review the definition, incidence, pathophysiology, and current risk prediction models for RVF and touch on the contemporary management of RVF perioperatively and post-LVAD implant.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalMethodist DeBakey cardiovascular journal
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Keywords

  • cardiac risk factors
  • heart assist device
  • heart failure
  • outcomes
  • right heart dysfunction

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Predictors and management of right heart failure after left ventricular assist device implantation'. Together they form a unique fingerprint.

Cite this